CAMP4 Therapeutics Corporation (CAMP) vs Pyxis Oncology, Inc. (PYXS)
CAMP4 Therapeutics Corporation and Pyxis Oncology, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Pyxis Oncology, Inc. are of similar size ($250.2M and $241.0M). Pyxis Oncology, Inc. has the higher net margin (0.00% vs −2,543.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Pyxis Oncology, Inc. leads on 7 and CAMP4 Therapeutics Corporation on 4.
Valuation
Profitability
| Metric | CAMP | PYXS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (1,254.22%) | 0.00% | 0.00% |
| Net margin | (2,543.74%) | 0.00% | 0.00% |
| Free cash flow margin | (680.36%) | 0.00% | 0.00% |
| Return on equity | (545.85%) | (179.10%) | (57.72%) |
| Return on assets | (148.23%) | (99.62%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack